This study is recruiting. It focuses on depression and currently lists participation information in the United States.
This study is looking at assess if nebulized ketamine can reduce depressive symptoms for people with depression or anxiety. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to nebulized ketamine, but direct benefit is not guaranteed.
The official record suggests a mix of remote and in-person participation through a clinic, with sites including Maimonides Medical Center in Brooklyn. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Mixes in-person and remote participation.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring observational follow-up for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Theresa Jacob, PhD, MPH. Based on the sponsor name or official registry information, it appears to be an individual investigator. You should verify the details in the official registry record.
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.